NCT07743112 — Acute Myeloid Leukemia trial site landscape

Public-registry site landscape for NCT07743112, a Acute Myeloid Leukemia study sponsored by Maxinovel Pty., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07743112 (registry record)
Sponsor	Maxinovel Pty., Ltd.
Condition(s)	Acute Myeloid Leukemia
Phase	PHASE2
Listed sites	1
Site countries	China

Recruiting-density context

At Institute of Institute of Hematology & Blood Diseases Hospital ( Chinese Academy of Medical Sciences) — one of the facilities listed on this trial — 5 other studies are actively recruiting Acute Myeloid Leukemia patients at the same facility (public registry, as of August 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07743112 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →